---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-061155"
form_type: "8-K"
ticker: "COO"
cik: "0000711404"
company_name: "COOPER COMPANIES, INC."
filed_at: "2026-09-09T20:34:31+00:00"
generated_at: "2026-09-09T20:35:09.577699+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# CooperCompanies Q3 EPS $2.24 GAAP, $1.15 non-GAAP; completes strategic review, buyback to $3B

## Summary
- Revenue $1.066B, +1% YoY; GAAP EPS $2.24 (incl. $307.2M tax benefit), non-GAAP EPS $1.15 (+4%).
- Free cash flow $273M, +66% YoY; repurchased $339.1M of stock in Q3.
- Strategic review complete: Board unanimously retains CooperSurgical; buyback authorization raised from $2B to $3B.
- FY2026 guidance: revenue $4.229-4.252B, non-GAAP EPS $4.51-4.55; Q4 revenue $1.057-1.080B, non-GAAP EPS $1.05-1.09.
- CooperVision revenue flat at $717M; CooperSurgical revenue $349.2M, +2% (organic +3%).

## SEC filing metadata
- accession: 0001628280-26-061155
- form_type: 8-K
- ticker: COO
- cik: 0000711404
- company_name: COOPER COMPANIES, INC.
- filed_at: 2026-09-09T20:34:31+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/711404/000162828026061155/0001628280-26-061155-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/711404/000162828026061155/coo-20260909.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-061155
- JSON: https://secwatch.observer/filing/0001628280-26-061155.json
- Plain text: https://secwatch.observer/filing/0001628280-26-061155.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.